Therefore, mice with hepatocyte‐specific Ubc9 deficiency manifested exacerbated senescent phenotype and were more susceptible to MCD‐induced MASLD and steatohepatitis. Here, UBE2I is linked to metabolic dysfunction-associated steatotic liver disease.